Lilly Asian Ventures

Lilly Asian Ventures

Lilly Asian Ventures

Overview
Date Founded

2008

Headquarters

Room 1504,1 Corporate Avenue, 222 Hubin Road,Huangpu,Shanghai 200021

Type of Company

Private

Industries

Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

LAV is an active manager which invests in seed-stage and listed and unlisted companies. The firm targets companies operating in the biopharmaceuticals sector, human therapeutics, medical devices, and diagnostics industries.It invests in young companies located in China and the United States.

Executives & Employees

Managing Partner

Managing Partner

Venture Partner

Partner

Investment Director

Principal

Vice President

Senior Manager

Senior Manager

Manager

Paths to Lilly Asian Ventures
Potential Connections via
Relationship Science
You
Lilly Asian Ventures
Recent Transactions
Details Hidden

Evotec SE purchases Just Biotherapeutics, Inc. from ARCH Venture Partners, Hillhouse Capital Management Ltd. /Invest, Temasek Capital Pte Ltd., Lilly Asian Ventures, Bank of China Investment Ltd., Beijing Taikang Investment Management Co., Ltd.

Details Hidden

Agilent Technologies, Inc. purchases ACEA Biosciences, Inc. from Qiming Venture Partners Ltd., Lilly Asian Ventures

Details Hidden

Lilly Asian Ventures, Veritas Genetics, Inc. purchase Curoverse, Inc. from Point Judith Capital Partners, MassVentures, Converge Venture Partners, Inc., Hatteras Venture Partners, Boston Global Ventures LLC

Investments
Details Hidden

Novast Holdings Ltd. manufactures pharmaceutical products. It focuses on design and development of difficult formulations containing challenging APIs for worldwide markets. The firm collaborates with pharmaceutical and biotechnology companies to develop and commercialize products for regulated markets. The company also provides product development services in novel technologies and drug delivery systems. Novast Holdings was founded by Guohua Zhang in 2005 and is headquartered in Nantong, China.

Details Hidden

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical intermediates and raw materials. Its products include prostaglandin, active pharmaceutical ingredient (API), fluorine, and intermediates. It also provide custom processing, research and development business. The company was founded by Zheng Zhi Guo, Liu Bin and Mou Li Zhi on April 22, 2010 and is headquartered in Taizhou, China.

Details Hidden

Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lilly Asian Ventures. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lilly Asian Ventures's profile does not indicate a business or promotional relationship of any kind between RelSci and Lilly Asian Ventures.